The confirmation of a successful in vitro fertilization (IVF) cycle frequently relies on biochemical analysis conducted to detect the presence of human chorionic gonadotropin (hCG). This hormone serves as a marker for pregnancy, typically measured via blood or urine samples following the introduction of a fertilized egg into the uterus. These assessments are scheduled to provide a reliable indication of implantation.
Accurate determination of conception following assisted reproductive technology offers significant psychological benefits, providing couples with definitive information after a period of anticipation and emotional investment. The practice also facilitates timely medical intervention if required, allowing for appropriate management of early pregnancy. Historically, the development of sensitive and specific assays for hCG detection has revolutionized the field of reproductive medicine, improving the efficiency and success rates of IVF procedures.